French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit Opella to a US ...

US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France. View on ...

Paris: French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit ...

French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health ...

Sanofi said the therapies developed by the new Orano Med entity will employ ... Orano Group, which is based in Paris and maintains U.S. headquarters in Bethesda, Maryland, provides products ...

US private equity firm Clayton Dubilier & Rice thought it had a deal to buy Sanofi’s consumer business. Losing bidder PAI ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

France’s Economy Minister has warned that the government could block the sale of a subsidiary of the French pharmaceutical ...

Politicians and groups from all sides have said the sale of the popular Doliprane drug would be a 'loss of sovereignty'.

In its revised bid, PAI pledged to preserve headcount and raise investments at Opella's French production sites of Lisieux in Normandy and Compiegne, the source said. It also vowed to keep Opella's ...

The French government has warned the United States investment company buying the consumer healthcare division of drugmaker ...

French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit to a US investment ...